ES2116660T3 - Clon adnc del virus de la encefalitis de tick-borne, vacunas recombinantes derivados de este y produccion de estos. - Google Patents

Clon adnc del virus de la encefalitis de tick-borne, vacunas recombinantes derivados de este y produccion de estos.

Info

Publication number
ES2116660T3
ES2116660T3 ES95111698T ES95111698T ES2116660T3 ES 2116660 T3 ES2116660 T3 ES 2116660T3 ES 95111698 T ES95111698 T ES 95111698T ES 95111698 T ES95111698 T ES 95111698T ES 2116660 T3 ES2116660 T3 ES 2116660T3
Authority
ES
Spain
Prior art keywords
tick
production
encephalitis virus
borne encephalitis
dna clone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95111698T
Other languages
English (en)
Inventor
Franz Xaver Prof Dr Heinz
Christian Prof Dr Kunz
Christian Doz Dr Mandl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of ES2116660T3 publication Critical patent/ES2116660T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UN CLON INFECCIOSO DEL VIRUS DE ENCEFALITIS (TBE) TICK-BORNE, QUE ABARCA LA SECUENCIA DE ACIDO NUCLEICO COMPLETA Y LAS VARIANTES O MUTANTES DERIVADOS DE ELLO, ASI COMO LA CODIFICACION PARA UNA TRANSCRIPCION DE TBEV-RNA INFECCIOSA. LA SECUENCIA DE ACIDO NUCLEICO ES CON PREFERENCIA UN CDNA CODIFICADO PARA TBEV-RNA INFECCIOSO Y MODIFICADO DE TAL MODO QUE GUIA HACIA LA FORMACION DE TBEV ATENUADOS, QUE PUEDEN SER UTILIZADOS PARA LA PRODUCCION DE VACUNAS.
ES95111698T 1994-07-27 1995-07-25 Clon adnc del virus de la encefalitis de tick-borne, vacunas recombinantes derivados de este y produccion de estos. Expired - Lifetime ES2116660T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4426622A DE4426622C1 (de) 1994-07-27 1994-07-27 Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben

Publications (1)

Publication Number Publication Date
ES2116660T3 true ES2116660T3 (es) 1998-07-16

Family

ID=6524280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95111698T Expired - Lifetime ES2116660T3 (es) 1994-07-27 1995-07-25 Clon adnc del virus de la encefalitis de tick-borne, vacunas recombinantes derivados de este y produccion de estos.

Country Status (9)

Country Link
EP (1) EP0698665B1 (es)
AT (1) ATE166388T1 (es)
CZ (1) CZ289713B6 (es)
DE (2) DE4426622C1 (es)
DK (1) DK0698665T3 (es)
ES (1) ES2116660T3 (es)
FI (1) FI117897B (es)
HU (1) HU222995B1 (es)
RU (1) RU2202612C2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19512142A1 (de) * 1995-03-31 1996-10-02 Immuno Ag Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält
DE19521705C2 (de) * 1995-06-14 1997-10-09 Immuno Ag Immunogenes Konstrukt, Verfahren zu dessen Herstellung und Verwendung als Vakzine
CN115044595A (zh) * 2022-05-16 2022-09-13 东北林业大学 检测人血清中蜱传脑炎病毒IgG抗体的酶联免疫测定试剂盒及其包被重组抗原的制备方法

Also Published As

Publication number Publication date
EP0698665A3 (de) 1996-10-23
RU2202612C2 (ru) 2003-04-20
DE59502231D1 (de) 1998-06-25
ATE166388T1 (de) 1998-06-15
FI953581A (fi) 1996-01-28
CZ185095A3 (en) 1996-02-14
FI117897B (fi) 2007-04-13
HU9502253D0 (en) 1995-09-28
EP0698665B1 (de) 1998-05-20
EP0698665A2 (de) 1996-02-28
DE4426622C1 (de) 1996-02-22
HUT72840A (en) 1996-05-28
HU222995B1 (hu) 2004-01-28
DK0698665T3 (da) 1999-02-15
FI953581A0 (fi) 1995-07-26
CZ289713B6 (cs) 2002-03-13

Similar Documents

Publication Publication Date Title
DE3879288D1 (de) Verfahren zur herstellung von polyglycerinen.
EP0762894A4 (en) METHOD FOR INDUCING IMMUNE REACTION USING A VENEZUELA EQUINE ENCEPHALITE VIVUS EXPRESSING A HETEROLOGOUS IMMUNOGENE
AR012034A1 (es) ANALOGO DE FACTOR X, DNA RECOMBINANTE QUE CODIFICA PARA DICHO ANALOGO DE FACTOR X Y SU USO, COMPOSICION QUE CONTIENE ANALOGO DE FACTOR X O UNA PROTEINAPRECURSORA DEL MISMO Y SU USO, PROCEDIMIENTO DE PREPARACION DE UNA COMPOSICION CONTENIENDO ANALOGO DE FACTOR X O ANALOGO DE FACTOR Xa O FACTOR Xa ACT
DE69332520T2 (de) Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
ES285248Y (es) Una protesis osea que tiene una superficie exterior acanala-da
ATE335831T1 (de) Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
DE69020623T2 (de) Glasfrit, verwendbar zur Herstellung von Glashohlkugeln, und daraus hergestellte Glashohlkugeln.
ES2091069T3 (es) Procedimiento de purificacion de pentafluoroetano.
NZ219002A (en) Method of modifying plant virus by pre-transforming plant genome
DE69525258D1 (de) Verfahren zur herstellung von hochfestem porzellan
ES2116660T3 (es) Clon adnc del virus de la encefalitis de tick-borne, vacunas recombinantes derivados de este y produccion de estos.
ES2122062T3 (es) Procedimiento para la limpieza de fibras huecas.
EP0947659A3 (de) Abstandhalterrahmen aus glasfaserverstärktem Kunststoff für Isolierglasscheiben und Verfahren zum Bilden von Ecken in einem solchen Abstandhalter
ES2074280T3 (es) Metodo para modificar el tropismo de celula, tejido o huesped de un microorganismo, microorganismos recombinantes obtenidos de este modo y su uso en medicina y medicina veterinaria.
ES8704975A1 (es) Un procedimiento para preparar un polipeptido que se puede utilizar en una vacuna para proteger seres humanos contra infeccion por plasmodium falciparum
AR247919A1 (es) Endo-1, 4-beta-glucanasa y secuencia de adn
CO5070712A1 (es) Nuevo procedimiento y compuestos obtenidos de este
DE59508988D1 (de) Vakzine zur Immunisierung gegen TBE-Virusinfektionen sowie ein Verfahren zu dessen Herstellung
DE59610629D1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
DE69031996T2 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
DE69331216T2 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
ATE132160T1 (de) Verfahren zur reinigung von aussenmembran-protein von haemophilus influenza
D'Albis Steps in the manufacture of the soft-paste porcelain of Vincennes, according to the books of Hellot
AR020324A1 (es) POLINUCLEOTIDO PARA LA TRANSCRIPCIoN DE ARN IN VIVO , MÉTODO PARA MODFICAR GENOTIPICA Y FENOTIPICAMENTE A UNA o MAS CÉLULAS, MÉTODO PARA PRODUCIR UNA PLANTA o TEJIDO DE PLANTA QUE COMPRENDE AL MENOS UNA CÉLULA GENOTíPICA O FENOTIPICAMENTE MODIFICADA
ATE118816T1 (de) Verfahren zur herstellung von acci- restriktionsendonuklease und -methylase.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 698665

Country of ref document: ES